ArteFill
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Suneva Medical announced this week that the injectable dermal filler ArteFill?® has been rebranded to Bellafill®.
ArteFill (Suneva Medical) may fill a void in the long-term treatment of acne scarring, initial study data indicates.
Suneva Medical has launched a multicenter phase 3 study to investigate the efficacy of the dermal filler Artefill…
Results from an interim analysis completed after 31 months of follow-up in a five-year prospective multicenter study represent…
San Diego — There are encouraging 18-month interim results from a prospective five-year safety and patient-satisfaction study on…
San Diego — Suneva Medical, a privately held aesthetic medical device company based here, has signed a multimillion-dollar line…
San Diego — Artes Medical has announced enrollment is completed in the 1,000-patient post-marketing study required by the Food…
National report — The Food and Drug Administration's (FDA) recent approval of the soft tissue filler Artefill (Artes Medical…
BACKGROUND. Artefill is one of several new materials being introduced to the US market as a soft tissue augmenting agent…
Artecoll is a dermal wrinkle filler that will be released in 2005 as Artefill. As one of the eight lead investigators for the U.S…